Literature DB >> 11404829

One-year dog toxicity study of D-002, a mixture of aliphatic alcohols.

C Alemán1, I Rodeiro, M Noa, R Menéndez, R Gaméz, C Hernandez, R Más.   

Abstract

D-002 is a mixture of high-molecular-weight aliphatic alcohols, obtained from bees wax (Apis mellifera), with mild anti-inflammatory properties and effective anti-ulcer activities demonstrated in experimental models. This study investigated the oral toxicity of D-002 administered for 1 year to beagle dogs. Twenty-four beagle dogs (12 males and 12 females) were distributed randomly in three experimental groups (four animals per group): a control and two treated groups received D-002 at 50 and 250 mg kg(-1) (7 days/week) by gastric gavage. Overall, D-002 was well tolerated throughout the study. No signs or symptoms of toxicity were observed, and no mortality occurred during the study. All groups showed similar weight gain and food consumption. No hematological, blood biochemical or histopathological disturbances attributable to treatment were observed. This study shows no drug-related toxicity induced by long-term administration of up to 250 mg kg(-1) D-002 to beagle dogs. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404829     DOI: 10.1002/jat.705

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  3 in total

1.  Protective effects of D-002 on experimentally induced gastroesophageal reflux in rats.

Authors:  Zullyt Zamora; Vivian Molina; Rosa Mas; Yazmin Ravelo; Yohany Perez; Ambar Oyarzabal
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

2.  Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis in hamsters.

Authors:  Y W Wang; P J H Jones; I Pischel; C Fairow
Journal:  Lipids       Date:  2003-02       Impact factor: 1.880

Review 3.  D-002 (beeswax alcohols): concurrent joint health benefits and gastroprotection.

Authors:  Vivian Molina; R Mas; D Carbajal
Journal:  Indian J Pharm Sci       Date:  2015 Mar-Apr       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.